Israel Englander Procaps Group, S.A. Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$3.84 - $5.04 $72,760 - $95,497	-18,948 Reduced 46.92%	21,432 $92,000
Q1 2023 May 15, 2023	SELL	$3.68 - $5.27 $103,422 - $148,108	-28,104 Reduced 41.04%	40,380 $182,000
Q4 2022 Feb 14, 2023	SELL	$4.89 - $7.37 $148,171 - $223,318	-30,301 Reduced 30.67%	68,484 $360,000
Q3 2022 Nov 14, 2022	SELL	$0.8 - $8.85 $2,116 - $23,408	-2,645 Reduced 2.61%	98,785 $691,000

104K

Ticker PROC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 112,824,000
Market Cap $283M
Description
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.